Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Lærke S Gasbjerg

1-31 of 31 results

View this query on the Wikidata Query Service
Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7.

scientific article published on 14 March 2013
The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor

scientific article
Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents

scientific article published in February 2018
GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study

scientific article
Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors

scientific article published on 25 January 2018
Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

scientific article published on 09 January 2019
Effect of Intracoronary and Intravenous Melatonin on Myocardial Salvage Index in Patients with ST-Elevation Myocardial Infarction: a Randomized Placebo Controlled Trial

scientific article
Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.

scientific article published on 13 June 2013
Signaling via G proteins mediates tumorigenic effects of GPR87.

scientific article published on 16 November 2016
Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

scientific article published in November 2017
Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes

scientific article published on 01 July 2019
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

scientific article published on 25 January 2019
GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men

scientific article published on 15 May 2019
GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2

scientific article published on 14 October 2019
Gluco-metabolic effects of oral and intravenous alcohol administration in men

scientific article published on 01 October 2019
The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID ‐19 in the capital region of Denmark

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats

scientific article published on 06 August 2019
Glucose-Dependent Insulinotropic Polypeptide Is Involved in Postprandial Regulation of Splanchnic Blood Supply

No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

scientific article published on 16 January 2020
Altered desensitization and internalization patterns of rodent versus human glucose‐dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge

scientific article published in July 2024
The dose-dependent efficacy of the glucose-dependent insulinotropic polypeptide receptor antagonist, GIP(3-30)NH2 , on GIP actions in humans

scientific article published on 04 September 2020
Proglucagon-derived peptides: human physiology and therapeutic potential

scientific article published in January 2026
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial

The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide

scientific article published on 8 August 2023
Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes

The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery

Acute effects of GIP and GLP ‐1 receptor antagonism in totally pancreatectomized individuals: A randomized double‐blind, placebo‐controlled crossover study

scientific article published on 10 October 2025
Oxytocin mRNA is expressed throughout the small intestine in individuals with and without type 2 diabetes, and circulating neurophysin I declines after Roux‐en‐Y gastric bypass surgery

Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes

GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly

The Role of Incretins on Insulin Function and Glucose Homeostasis

scientific article published on 30 March 2021

Paulina is supported by:

About Paulina

Help